TWC
XRTX

TD Waterhouse Canada’s XORTX Therapeutics XRTX Stock Holding History

TD Waterhouse Canada’s Portfolio XRTX Stock Details XRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19 Buy
+9
New +$21 ﹤0.01% 2275

Other funds holding XRTX

KWM
Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return

TD Waterhouse Canada's XRTX Position: Q1 2026 in Review

TD Waterhouse Canada opened a new position in XORTX Therapeutics (XRTX) in Q1 2026: 9 shares worth $19. The stake represents ﹤0.01% of the portfolio and ranks #2275 among its holdings.

3 funds tracked by Wall St. Rank hold XRTX as of Q1 2026.

  • TD Waterhouse Canada held 9 shares of XORTX Therapeutics worth $19 as of Q1 2026.
  • XORTX Therapeutics was a new TD Waterhouse Canada position in Q1 2026.
  • XORTX Therapeutics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #2275 holding.
  • 3 funds tracked by Wall St. Rank held XORTX Therapeutics as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.